LCM
Lynx1 Capital Management Portfolio holdings
AUM
$346M
This Quarter Return
+295.98%
1 Year Return
-2.97%
3 Year Return
+1,498.67%
5 Year Return
–
10 Year Return
–
AUM
$116M
AUM Growth
+$116M
(+4.3%)
Cap. Flow
+$16.8M
Cap. Flow
% of AUM
14.56%
Top 10 Holdings %
Top 10 Hldgs %
98.03%
Holding
16
New
4
Increased
7
Reduced
2
Closed
3
Top Buys
| 1 |
Cabaletta Bio
CABA
|
$26.1M |
| 2 |
Merus
MRUS
|
$3.74M |
| 3 |
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
|
$2.2M |
| 4 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
$1.97M |
| 5 |
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
|
$1.39M |
Top Sells
| 1 |
BLU
BELLUS Health Inc.
BLU
|
$10.6M |
| 2 |
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
|
$4.58M |
| 3 |
CBAY
Cymabay Therapeutics
CBAY
|
$4.22M |
| 4 |
Immunic
IMUX
|
$3.39M |
| 5 |
OTIC
Otonomy, Inc.
OTIC
|
$682K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cabaletta Bio
CABA
$133M
| $26.1M | 22.61% | +2,825,976 | New | +$26.1M |
|
|
ALPN
2
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $23M | 19.87% | 3,126,173 +69,753 | +2% | +$513K |
|
|
3
Merus
MRUS
$4.98B
| $13.2M | 11.43% | 854,591 +241,520 | +39% | +$3.74M |
|
|
KNTE
4
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $12.2M | 10.54% | 1,998,417 +323,740 | +19% | +$1.97M |
|
|
CBAY
5
DELISTED
Cymabay Therapeutics
CBAY
| $10.4M | 8.97% | 1,653,495 -672,338 | -29% | -$4.22M |
|
|
BLU
6
DELISTED
BELLUS Health Inc.
BLU
| $8.99M | 7.78% | 1,093,900 -1,288,227 | -54% | -$10.6M |
|
|
PVLA
7
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $5.85M | 5.06% | 5,628,585 +2,113,445 | +60% | +$2.2M |
|
|
PRDS
8
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $5.08M | 4.39% | 3,003,102 +727,370 | +32% | +$1.23M |
|
9
Passage Bio
PASG
$22.7M
| $4.63M | 4.01% | 3,355,917 +603,495 | +22% | +$833K |
|
|
THRX
10
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $3.91M | 3.38% | 784,158 +279,296 | +55% | +$1.39M |
|
11
Neurogene
NGNE
$264M
| $1.17M | 1.01% | +2,291,133 | New | +$1.17M |
|
|
WHWK
12
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $831K | 0.72% | +64,739 | New | +$831K |
|
13
Pharvaris
PHVS
$1.39B
| $285K | 0.25% | +25,325 | New | +$285K |
|
|
JBIO
14
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| – | – | -276,447 | Closed | -$4.58M |
|
|
15
Immunic
IMUX
$80.9M
| – | – | -1,072,288 | Closed | -$3.39M |
|
|
OTIC
16
DELISTED
Otonomy, Inc.
OTIC
| – | – | -2,312,880 | Closed | -$682K |
|